Stratistics Market Research Consulting

Antithrombotic Drugs Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022.

Press Release   •   Aug 08, 2017 02:55 EDT

According to Stratistics MRC, the Global Antithrombotic Drugs market is accounted for $XX million in 2016 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2016 to 2022. Rising prevalence of chronic diseases associated with thrombotic disease require long-term administration of antithrombotic drugs, which is the key factor enhancing the demand for antithrombotic drugs market. Furthermore, growing geriatric population, increasing hereditary diseases, lack of physical activity, increasing awareness among patients about life-threatening diseases, changing lifestyles and increasing hypertension are the factors favouring market growth. However, off- patented drugs, postoperative bleeding and availability of generic antithrombotic drugs would restrict the antithrombotic drugs market growth. Furthermore, new product launches by key vendors, up-gradation in the antithrombotic drugs and recent R&D programs by major players to develop new drugs are the key opportunities for the market.

Asia Pacific is expected to grasp major revenue and volume share in antithrombotic drugs market and is expected to grow with a high CAGR during the forecast period. This growth is attributed to increasing patient population in China and India. North America and Europe regions have significant penetration of antithrombotic drugs due to continual R&D activities for new drug development and high prevalence rate of cardiac and cancer diseases.

Some of the key global players in antithrombotic drugs market are Bayer AG, Johnson & Johnson Services Inc., Sanofi, Boehringer Ingelheim GmbH, Pfizer Inc., Abbott laboratories, Dr. Reddy’s Laboratories, Pharmacia Inc., Eli Lilly and Company, The Medicines Company, Genentech Inc., Bristol-Myers Squibb., Watson laboratories inc, Zydus pharmaceuticals Inc. and Otsuka.

For More, Please Visit:

Drug Types Covered:
• Anticoagulant
• Thrombolytic drugs
• Antiplatelet

Drug Classes Covered:
• Edoxaban
• Fondaparinux
• Heparin
• Apixaban
• Debigatran
• Rivaroxaban

Indications Covered:
• Myocardial infarction (MI)
• Venous thromboembolism (VTE)
• Stroke
• Acute coronary syndrome (ACS)
• Peripheral arterial occlusion (PAO)
• Other Indications

Route of Administration Covered:
• Oral route
• Parenteral route

Applications Covered:
• Blood clot prevention
• Hyperlipidemia treatment
• Prophylactic treatment
• Thromboembolic disease treatment
• Other Applications

Distribution Channels Covered:
• Hospital Pharmacies
• Online Retailers
• General Pharmacies
• Drug Stores

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For More, Please Visit:

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.